<?xml version="1.0" encoding="UTF-8" standalone="yes"?><EventTranscript id="2755284"><Name>Q4 2009 Nektar Therapeutics Earnings Conference Call</Name><Company>Nektar Therapeutics</Company><Drugs><Drug>bevacizumab</Drug><Drug>opioid analgesic (formulated with abuse-deterrent naloxol, pain), AstraZeneca</Drug><Drug>NKTR-181</Drug><Drug>pegfilgrastim</Drug><Drug>amikacin (inhaled, Aeroneb), Bayer</Drug><Drug>NKTR-194</Drug><Drug>docetaxel (pegylated, cancer), Nektar</Drug><Drug>NKTR-171</Drug><Drug>the-105</Drug><Drug>naloxegol</Drug><Drug>docetaxel</Drug><Drug>etirinotecan pegol</Drug><Drug>irinotecan</Drug><Drug>paroxetine hydrochloride hemihydrate</Drug></Drugs></EventTranscript>